Vallera BachanovaThe Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community.

About the Masonic Cancer Center

Read the 2015 biannual report

Announcements

Cancer and the Human Body at the Science Museum of Minnesota

The Science Museum and the Masonic Cancer Center, University of Minnesota invite you to the Cancer and the Human Body event, 12-4 p.m., Saturday, March 4, 2017. Learn the basics about a disease that touches so many lives each year—from cancer biology to laboratory research and treatment methods. Discover the amazing tools physicians can use to fight the disease, meet scientists active in the field, and ask questions about current trends in the study of cancer. More information

Patient Care

Ed Greeno with patient

M Health logo


The Masonic Cancer Center's clinical partner is University of Minnesota Health. Visit mhealth.org/cancer to find information about cancer care, providers and cancer clinic locations.

Cancer Information Nurse Line

Reach a nurse specializing in cancer care, Monday through Friday from 8 a.m. to 4:30 p.m.

Phone: 612-624-2620
Email: ccinfo@umn.edu

Clinical Trials

Glove and vial

New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made widely available. Through clinical trials, researchers learn which approaches are more effective than others.

Our Research Focus

Jeffrey Miller, M.D.

The Masonic Cancer Center brings together scientists from different disciplines to discover processes that affect cancer. It is home to state-of-the-art research tools and some of the world's top cancer researchers in:

Featured News

Drs. Modiano and Borgatti with dog Valky

Drug developed at University of Minnesota increases survival in dogs with cancer; shows potential for use in humans

MINNEAPOLIS/ST.PAUL (February 13, 2017) – A breakthrough trial at the University of Minnesota testing a new UMN-developed drug resulted in improved survival rates for dogs diagnosed with a cancer called hemangiosarcoma (HSA). The results were published today in the journal Molecular Cancer Therapeutics.

Dr. Robert Kratzke

Masonic Cancer Center Professor Elected Chair of the Big Ten CRC Steering Committee

MINNEAPOLIS/ST. PAUL (December 23, 2016) – The Big Ten Cancer Research Consortium (Big Ten CRC) elected Robert Kratzke, M.D., lung cancer researcher, Masonic Cancer Center, University of Minnesota and associate professor in the University of Minnesota Medical School's Department of Medicine, as its inaugural Steering Committee Chair. Kratzke will lead the initiative to transform cancer research through collaboration across Big Ten universities.

NCI Designated Comprehensive Cancer Center

Masonic Cancer Research BuildingMasonic Cancer Center, founded in 1991, is a National Cancer Institute Comprehensive Cancer Center, one of only 47 institutions in the United States and two in Minnesota to hold that designation. 

Masonic Cancer Center Celebrates 25 Years
Masonic Cancer Center Celebrates 25 Years

Cancer and Cardiovascular Research Building

Cancer Cardiovascular Research BuildingA state-of-the-art facility with 52,000 square feet of laboratory space, which expands the opportunities for collaborative research at the Masonic Cancer Center. It's the gateway to the Biomedical Discovery District.